ASX:TRP

Tissue Repair (TRP) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free TRP Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Tissue Repair alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

TRP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive TRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tissue Repair and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: ASX:TRP
CUSIP: N/A
CIK: N/A
Web: www.tcenergy.com
Phone: 14039202000
Fax: N/A
Employees: 7,283
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.06)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,280,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -15.47%
Return on Assets: -11.19%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 26.16
Quick Ratio: 46.23

Sales & Book Value

Annual Sales: $1.03 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.33 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 55,810,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.22

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Tony Charara
Co-Founder & Executive Director
Mr. Cameron Jones C.A.
Chief Financial Officer
Dr. Darryl Reed
Chief Operating Officer
Ms. Sushma Kejriwal
Company Secretary

Key Competitors

View All Competitors

Insiders

This page (ASX:TRP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tissue Repair (TRP) Stock Price, News & Analysis

About Tissue Repair

TRP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info